Home / PHLDA1 Knockout Cell Lines

PHLDA1 Knockout Cell Lines

Gene: PHLDA1

Official Full Name: pleckstrin homology like domain family A member 1provided by HGNC

Gene Summary: This gene encodes an evolutionarily conserved proline-histidine rich nuclear protein. The encoded protein may play an important role in the anti-apoptotic effects of insulin-like growth factor-1. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO03035 PHLDA1 Knockout cell line (HeLa) Human PHLDA1 1:3~1:6 Negative Online Inquiry
KO03036 PHLDA1 Knockout cell line (HCT 116) Human PHLDA1 1:2~1:4 Negative Online Inquiry
KO03037 PHLDA1 Knockout cell line (HEK293) Human PHLDA1 1:3~1:6 Negative Online Inquiry
KO03038 PHLDA1 Knockout cell line (A549) Human PHLDA1 1:3~1:4 Negative Online Inquiry

Background

PHLDA1 Gene Knockout Cell Lines are genetically modified cellular models specifically designed to lack the PHLDA1 gene, which plays a critical role in various biological processes, including apoptosis and cellular differentiation. This knockout model allows researchers to explore the functional implications of PHLDA1 deficiency in a controlled environment, facilitating comprehensive studies on cancer progression, immune responses, and developmental biology.

The key mechanism behind these cell lines involves the targeted disruption of the PHLDA1 gene through CRISPR/Cas9 technology or homologous recombination, ensuring that all cellular functions associated with this gene are effectively abrogated. This enables scientists to investigate the downstream effects of PHLDA1 loss, especially in tissues known to be influenced by its expression, providing insights into pathological states where PHLDA1 modulation occurs.

In research and clinical settings, PHLDA1 Gene Knockout Cell Lines hold significant value for elucidating the role of PHLDA1 in cancer biology. Studies have shown that PHLDA1 acts as a tumor suppressor in various malignancies. Therefore, these cell lines can serve as model systems for drug screening and the identification of therapeutic targets, enhancing our understanding of potential new treatments.

Compared to alternative models, these cell lines offer unparalleled specificity and reliability, allowing precise manipulation of cellular pathways associated with PHLDA1. Unlike transient knockdown approaches, knockout cell lines provide stable expression profiles suitable for long-term experiments, significantly enhancing reproducibility and data integrity.

For researchers and clinicians, the availability of PHLDA1 Gene Knockout Cell Lines represents a crucial tool that drives innovation in cancer research, potentially leading to breakthroughs in cancer treatment strategies. Furthermore, our company boasts extensive expertise in genetic engineering and cell line development, ensuring that our products meet the highest standards of quality and scientific rigor. With our commitment to advancing biological research, we empower the scientific community to uncover new discoveries.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.